Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symetria Recovery is a private U.S. outpatient addiction treatment company focused on opioid, alcohol, and broader substance use disorders. Founded in 2006 and headquartered in Naperville, Illinois, the company operates a multi-site clinic network in Illinois and Texas. Its care model, The Symetria Method, integrates medication-assisted treatment, psychiatry, behavioral counseling, intensive outpatient programming, and on-site pharmacy services within a single outpatient setting. Symetria is particularly specialized in opioid use disorder treatment and provides access to FDA-approved medications such as methadone, buprenorphine, Suboxone, and naltrexone. The business is best characterized as a healthcare delivery and behavioral health services company rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symetria Recovery.